Sean Parker's $250 million initiative is revolutionising cancer research by breaking down institutional silos. By fostering collaboration and creating a unified data pipeline among leading cancer centres, the Parker Institute is accelerating the development of targeted immunotherapies. This approach overcomes data fragmentation, enabling faster validation of theories and streamlining clinical...